ASH Announces Congressional Fellowship, ASH Clinical Practice Guidelines on Sickle Cell Disease, and more

Announcing the ASH Congressional Fellowship

The ASH Congressional Fellowship is a new program, offered through a partnership with the American Association for the Advancement of Science (AAAS), that allows ASH members with an interest in health policy to work with members of Congress for an academic year.

The selected fellows will develop scientific and evidence-based policy expertise, giving them the foundation to pursue a career path in health policy. At the same time, the program benefits ASH by extending the Society’s reach and visibility on Capitol Hill and facilitating partnerships between ASH and congressional offices.

The ASH Congressional Fellowship builds on the ASH Advocacy Leadership Institute (ALI), a two-day workshop that allows ASH members to learn more about advocacy, health policy, and the legislative process, and to become further engaged in the Society’s activities. The Fellowship program begins with a two-week orientation followed by a year-long placement in the congressional office of the ASH member’s choice.

Visit hematology.org/congressionalfellowship for more information, including eligibility requirements. The application deadline is January 31, 2017.


ASH Awards – Deadlines Fast Approaching in Early 2017 

Updates to ASH Research Training Award for Fellows

The ASH Research Training Award for Fellows (RTAF) is designed to encourage junior researchers in hematology, hematology/oncology, or other hematology-related training programs to pursue a career in academic hematology. The goals of this program are to encourage and support research (clinical, basic science, or translational), promote mentorship of hematology trainees by outstanding faculty members, produce clinician scientist candidates for academic positions, and provide bridging funds for trainees.

Awards, to be used primarily for salary support for the applicant, target two separate groups of researchers:

  • junior investigator RTAF for second- or third-year fellows whose research has been initiated but which has not yet generated preliminary data (apply in years 1 or 2 of fellowship)
  • senior investigator RTAF for fourth- or fifth-year fellows whose projects have been initiated and have generated data (apply in years 3 or 4 of fellowship)

The RTAF award amount has increased from $55,000 to $70,000 per year for 2017. MD/PhDs may now apply for the RTAF; six MD/PhD awards will be granted each year, in addition to the six awards for MDs. Award recipients may apply for a renewal for one additional year (up to four people will be awarded a renewal each year).

Visit hematology.org/Awards/Career-Training/435.aspx for more information. The application deadline is January 15, 2017.

A New Flexible MMSAP Research Experience Offered in 2017

ASH is accepting applications for the 2017 Minority Medical Student Award Program (MMSAP). MMSAP provides minority medical students with the opportunity to learn about the field of hematology, gain first-hand research experience in the lab of an ASH member, and receive valuable guidance from both a research and a career-development mentor. “The MMSAP gave me an opportunity to conduct research with very little experience. The mentorship received during the program is something that is not offered everywhere,” said Felicia M. Austin, 2015 MMSAP participant.
The program offers the following eight- to 12-week research options:

  • a summer research experience for minority medical students between their first and second year of medical school, to be conducted during the summer break with a laboratory- or clinically based hematology investigator
  • a flexible research experience for minority medical students in their first, second, or third year of medical school, to be completed over the course of a year (approximately 320- to 480-hour commitment)

After the research experience, students attend the ASH annual meeting, where they present their research findings at the Promoting Minorities in Hematology Presentations and Reception. Additionally, participants may apply for a second summer research experience and are encouraged to remain involved with ASH throughout medical school and residency to continue on the path to a career in hematology.

Visit hematology.org/Awards/Medical-Student/383.aspx for application information. The application deadline is February 1, 2017.

Application Process Open for the Minority Resident Hematology Award Program

ASH is accepting applications for the Minority Resident Hematology Award Program (MRHAP). MRHAP provides support for underrepresented minority residents to conduct hematology-focused research. The intended outcome is to increase interest in hematology research and influence fellowship choice. Individuals from the following groups are encouraged to apply:

  • medical residents who are enrolled in an internal medicine, pathology, or pediatric residency program
  • resident physicians who have applied to or matched into a hematology/oncology fellowship program

After the research experience, MRHAP participants attend the ASH annual meeting, where they present the results of their projects at the Promoting Minorities in Hematology Presentations and Reception. Attendance at the ASH annual meeting provides residents with outstanding opportunities to meet prominent leaders in the field of hematology, network with other MRI program participants, and hear the latest breaking news in the field.

Visit hematology.org/Medical-Student/MRHAP for application information. The application deadline is February 1, 2017.


ASH and Partners Receive Grant to Address Knowledge Gaps in Acute Myeloid Leukemia Care

The American Society of Hematology (ASH) has partnered with several organizations on independent educational programming designed to help address knowledge gaps in the diagnosis and treatment of acute myeloid leukemia (AML). The American Society for Clinical Pathology (ASCP), the Oncology Nursing Society (ONS), the National Marrow Donor Program®/Be The Match®, and The France Foundation have joined ASH to create and implement a specialized curriculum, titled “Acute Myeloid Leukemia MATTERS: A Multidisciplinary Approach To Testing and Diagnosis, Evaluation of Risk, and Personalized Treatment Selection.” ASH received educational grant funding from Celgene Corporation to support this initiative.

“Caring for a patient with a challenging disease like AML requires the collaborative efforts of a highly skilled multidisciplinary team,” said 2016 ASH President Charles S. Abrams, MD. “ASH is pleased to join a diverse and committed group of partners who represent all of the different types of providers who comprise the team that cares for AML patients. By improving the way AML is approached from the bench to the bedside, we will change the survival prognosis for our patients.”

The curriculum, which will begin in 2017, includes four educational summits, presentations at both the ASH and ASCP annual meetings, and the creation of updated educational materials for physicians and nurses.


ASH Seeks Editor-in-Chief for The Hematologist

ASH is in the initial stage of the selection process for the next Editor-in-Chief of The Hematologist (term: 2018-2020). Candidates with an MD or equivalent medical degree should have the following: a broad and comprehensive knowledge of basic research and clinical investigation in hematology as well as an appreciation of its subspecialty areas; a distinguished research and publications record; high standing among peers; and demonstrated writing, reviewing, and editing skills.

Members of ASH are invited to submit the names of potential candidates, accompanied by a brief, informal endorsement and a description of the candidate’s editorial experience, to Juana Llorens, Managing Editor, at [email protected].

The application deadline is February 1, 2017.


Call for Patient Volunteers: ASH Clinical Practice Guidelines on Sickle Cell Disease

ASH is developing new clinical practice guidelines on the management of acute and chronic complications of SCD. ASH has formed five guideline panels to examine different aspects of SCD including pain, cardiopulmonary/kidney disease, cerebrovascular disease, transfusions, and transplantation. ASH invites non-physician volunteers to serve as patient representatives on the five panels. ASH wants to ensure that the panels give attention to the perspective of patients. If you would like to participate or have questions about this opportunity, please contact Starr Webb, MPH, Clinical Quality Projects Manager, at [email protected].

If you are interested in getting regular updates about ASH’s Sickle Cell Disease Initiative and other SCD news and activities, sign up at scdcoalition.org/get-email-updates.html.

The final date for receiving volunteers is December 31, 2016.

SHARE